Related references
Note: Only part of the references are listed.APOEε4 potentiates the relationship between amyloid-β and tau pathologies
Joseph Therriault et al.
MOLECULAR PSYCHIATRY (2021)
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
Enrico Fantoni et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Association of Apolipoprotein E epsilon 4 With Medial Temporal Tau Independent of Amyloid-beta
Joseph Therriault et al.
JAMA NEUROLOGY (2020)
Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
Reisa A. Sperling et al.
JAMA NEUROLOGY (2020)
Association of amyloid-beta CSF/PET discordance and tau load 5 years later
Juhan Reimand et al.
NEUROLOGY (2020)
Quantification of [18F]florbetapir: A test-retest tracer kinetic modelling study
Sandeep S. V. Golla et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Gil D. Rabinovici et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
A brief history of Alzheimer disease Multiple meanings separated by a common name
David S. Knopman et al.
NEUROLOGY (2019)
Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease
Oskar Hansson et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
Clifford R. Jack et al.
BRAIN (2019)
Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease
Maria Joao Leitao et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
Lyduine E. Collij et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F]THK5351 uptake in progressive supranuclear palsy
Kok Pin Ng et al.
NEUROIMAGE-CLINICAL (2019)
Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab
Ping Chiao et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol
Santiago Bullich et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition
Val J. Lowe et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future
K. Blennow et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
Leslie M. Shaw et al.
ALZHEIMERS & DEMENTIA (2018)
Cerebrospinal Fluid A beta(42/40) Corresponds Better than A beta(42) to Amyloid PET in Alzheimer's Disease
Piotr Lewczuk et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population
Daniela Bertens et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve et al.
BRAIN (2015)
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
Niklas Mattsson et al.
BRAIN (2015)
Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
Lennart Thurfjell et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
ALZHEIMERS & DEMENTIA (2013)
Comparing Positron Emission Tomography Imaging and Cerebrospinal Fluid Measurements of β-Amyloid
Susan M. Landau et al.
ANNALS OF NEUROLOGY (2013)
Amyloid-beta Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods
Susan M. Landau et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia
Christopher C. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant
Elizabeth C. Mormino et al.
NEUROIMAGE (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Atrophy-specific MRI brain template for Alzheimer's disease and mild cognitive impairment
Vladimir Fonov et al.
Alzheimers & Dementia (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand
Anders Jureus et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Amyloid PET Ligands for Dementia
Victor L. Villemagne et al.
PET CLINICS (2010)
Standards for PET Image Acquisition and Quantitative Data Analysis
Ronald Boellaard
JOURNAL OF NUCLEAR MEDICINE (2009)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Mild cognitive impairment as a diagnostic entity
RC Petersen
JOURNAL OF INTERNAL MEDICINE (2004)
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
CA Mathis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Neuropathology of cognitively normal elderly
DS Knopman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Share Paper
